BioCardia, Inc. (BCDA)

NASDAQ: BCDA · IEX Real-Time Price · USD
0.415
-0.004 (-0.98%)
Mar 28, 2024, 1:23 PM EDT - Market open

Total Valuation

BioCardia has a market cap or net worth of $10.86 million. The enterprise value is $11.07 million.

Market Cap 10.86M
Enterprise Value 11.07M

Important Dates

The last earnings date was Wednesday, March 27, 2024, before market open.

Earnings Date Mar 27, 2024
Ex-Dividend Date n/a

Share Statistics

BioCardia has 25.91 million shares outstanding. The number of shares has increased by 19.52% in one year.

Shares Outstanding 25.91M
Shares Change (YoY) +19.52%
Shares Change (QoQ) +4.21%
Owned by Insiders (%) 36.24%
Owned by Institutions (%) 8.04%
Float 14.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 22.77
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 23.21
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.41

Current Ratio 0.41
Quick Ratio 0.32
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -3,638.70%.

Return on Equity (ROE) -3,638.70%
Return on Assets (ROA) -228.60%
Return on Capital (ROIC) n/a
Revenue Per Employee $15,900
Profits Per Employee -$385,700
Employee Count 30
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.04% in the last 52 weeks. The beta is 1.50, so BioCardia's price volatility has been higher than the market average.

Beta (1Y) 1.50
52-Week Price Change -80.04%
50-Day Moving Average 0.44
200-Day Moving Average 0.84
Relative Strength Index (RSI) 47.80
Average Volume (30 Days) 391,468

Short Selling Information

The latest short interest is 1.01 million, so 3.91% of the outstanding shares have been sold short.

Short Interest 1.01M
Short Previous Month 98,275
Short % of Shares Out 3.91%
Short % of Float 6.94%
Short Ratio (days to cover) 0.32

Income Statement

In the last 12 months, BioCardia had revenue of $477,000 and -$11.57 million in losses. Loss per share was -$0.55.

Revenue 477,000
Gross Profit 477,000
Operating Income -11.64M
Pretax Income -11.57M
Net Income -11.57M
EBITDA -11.16M
EBIT -11.57M
Loss Per Share -$0.55
Full Income Statement

Balance Sheet

The company has $1.10 million in cash and $1.32 million in debt, giving a net cash position of -$212,000 or -$0.01 per share.

Cash & Cash Equivalents 1.10M
Total Debt 1.32M
Net Cash -212,000
Net Cash Per Share -$0.01
Equity / Book Value -1.60M
Book Value Per Share -0.06
Working Capital -2.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.97 million and capital expenditures -$12,000, giving a free cash flow of -$9.99 million.

Operating Cash Flow -9.97M
Capital Expenditures -12,000
Free Cash Flow -9.99M
FCF Per Share -$0.47
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -2,441.09% and -2,425.79%.

Gross Margin 100.00%
Operating Margin -2,441.09%
Pretax Margin -2,425.79%
Profit Margin -2,425.79%
EBITDA Margin -2,339.62%
EBIT Margin -2,425.79%
FCF Margin -2,093.50%

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -19.52%
Shareholder Yield -19.52%
Earnings Yield -106.54%
FCF Yield -91.95%

Analyst Forecast

The average price target for BioCardia is $4.00, which is 863.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.00
Price Target Difference 863.86%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 87.39%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on June 6, 2019. It was a reverse split with a ratio of 1:9.

Last Split Date Jun 6, 2019
Split Type Reverse
Split Ratio 1:9

Scores

BioCardia has an Altman Z-Score of -83.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -83.39
Piotroski F-Score 2